¾È°ú¿ë ÀǾàǰ ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2033³â) : À¯Çüº°, Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Çüź°, Àç·á À¯Çüº°, ±â±¸º°, °øÁ¤º°
Ophthalmic Drugs Market Analysis and Forecast to 2033: Type, Product, Technology, Application, End User, Form, Material Type, Device, Process
»óǰÄÚµå : 1598990
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 306 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,628,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 8,023,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,418,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¾È°ú¿ë ÀǾàǰ ½ÃÀå ±Ô¸ð´Â 2023³â 389¾ï ´Þ·¯¿¡¼­ 2033³â±îÁö 687¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ ¾à 6.1%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

½ÃÀå¿¡´Â ¾È°ú °ü·Ã ÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ ÀǾàǰÀÇ °³¹ß, »ý»ê, À¯ÅëÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â ³ì³»Àå, ¾È±¸°ÇÁ¶Áõ, ¸Á¸·Áúȯ µîÀÇ ÁúȯÀ» ´ë»óÀ¸·Î Çϴ ó¹æ¾à°ú OTC ÀǾàǰÀÌ Æ÷ÇԵ˴ϴÙ. °í·ÉÈ­, ¾ÈÁúȯ À¯º´·ü Áõ°¡, ¾à¹°Àü´Þ ±â¼úÀÇ ¹ßÀüÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦¾à »ê¾÷¿¡¼­ ±â¼ú Çõ½Å°ú È®ÀåÀÇ Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÁÖ·Î ¾È°ú °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü¿¡ ÈûÀÔ¾î °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¸Á¸· Áúȯ, ƯÈ÷ ³ëÈ­ Ȳ¹Ýº¯¼º ¹× ´ç´¢¸Á¸·º´ÁõÀº Àü ¼¼°è ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ´ç´¢º´ ȯÀÚÀÇ Áõ°¡·Î ÀÎÇØ ÁÖ¿ä ÇÏÀ§ ºÎ¹®À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ³ì³»Àå Ä¡·áÁ¦´Â ÀÎ½Ä °³¼±°ú Á¶±â Áø´ÜÀ» À§ÇÑ ³ë·Â¿¡ ÈûÀÔ¾î µÎ ¹øÂ°·Î ³ôÀº ¼º°ú¸¦ °ÅµÐ ÇÏÀ§ ºÎ¹®ÀÔ´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ÀÇ·áºñ ÁöÃâ¿¡ ÈûÀÔ¾î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±× µÚ¸¦ À̾î À¯·´Àº °í·ÉÈ­¿Í Á¤ºÎ Áö¿ø Á¤Ã¥À¸·Î ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Â µ¶Àϰú ¿µ±¹ÀÌ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÅõÀÚ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ´ë±Ô¸ð ȯÀÚ Àα¸·Î ÀÎÇØ À¯¸®ÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿Í ÀÇ·á ½Ã¼³ÀÇ Áö¼ÓÀûÀÎ °³¼±À¸·Î ÀÎÇØ ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ¾È°ú¿ë ÀǾàǰ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, ÁúÀû/¾çÀû µ¿Çâ, ¿ªÇÐ, ºñÁî´Ï½º ÇÁ·¹ÀÓ¿öÅ©, °æÀï »óȲ, ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®

Á¦4Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå Àü¸Á

Á¦5Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå Àü·«

Á¦6Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå ±Ô¸ð

Á¦7Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : À¯Çüº°

Á¦8Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : Á¦Ç°º°

Á¦9Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : ±â¼úº°

Á¦10Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : ¿ëµµº°

Á¦11Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : Çü½Äº°

Á¦13Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : Àç·á À¯Çüº°

Á¦14Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : ±â±¸º°

Á¦15Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦16Àå ¾È°ú¿ë ÀǾàǰ ½ÃÀå : Áö¿ªº°

Á¦17Àå °æÀï »óȲ

Á¦18Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The ophthalmic drugs market is anticipated to expand from $38.9 billion in 2023 to $68.7 billion by 2033, reflecting a CAGR of approximately 6.1%.

The ophthalmic drugs market encompasses the development, production, and distribution of medications designed to treat eye-related conditions. This market includes prescription and over-the-counter drugs targeting ailments such as glaucoma, dry eye syndrome, and retinal disorders. It is driven by an aging population, increasing prevalence of eye diseases, and advancements in drug delivery technologies, offering significant opportunities for innovation and expansion within the pharmaceutical industry.

The ophthalmic drugs market is witnessing robust growth, primarily driven by the increasing prevalence of eye-related disorders and technological advancements in drug delivery systems. Retinal disorders, particularly age-related macular degeneration and diabetic retinopathy, are the leading sub-segments, owing to the rising geriatric population and increasing diabetes cases globally. Glaucoma medications represent the second-highest performing sub-segment, supported by growing awareness and early diagnosis initiatives. Geographically, North America leads the market, propelled by advanced healthcare infrastructure and high healthcare expenditure. Europe follows closely, with significant contributions from countries like Germany and the United Kingdom, where the aging population and supportive government policies enhance market growth. The Asia-Pacific region is emerging as a lucrative market, driven by increasing healthcare investments, rising disposable incomes, and a large patient pool. This region is expected to experience rapid growth due to expanding access to healthcare services and ongoing improvements in healthcare facilities.

Key Companies

Santen Pharmaceutical, Bausch + Lomb, Alcon, Regeneron Pharmaceuticals, Allergan, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Nicox, Kala Pharmaceuticals, Eye Point Pharmaceuticals, Aldeyra Therapeutics, Harrow Health, Graybug Vision, Eyenovia, Meira GTx, Ocugen, Ohr Pharmaceutical, Gen Sight Biologics, Pro QR Therapeutics, Visionary Pharma, Opti Medica Solutions, Clear Sight Therapeutics, Ocu Bright Innovations, Nex Gen Ophthalmics, Eye Cure Biotech, Focus Vision Pharmaceuticals, Lumi Lens Labs, Vista Genix Therapeutics, Ocularis Biopharma, Sight Line Pharmaceuticals, Clarity Vision Sciences, Opti Nova Therapeutics, Eye Viva Labs, Vision Quest Biotech, Inno Sight Pharmaceuticals, Ocu Thera Innovations, Visionary Biologics, Opti Clear Solutions, Eye Genix Pharmaceuticals

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1. Ophthalmic Drugs Market Overview

2. Executive Summary

3. Premium Insights on the Market

4. Ophthalmic Drugs Market Outlook

5. Ophthalmic Drugs Market Strategy

6. Ophthalmic Drugs Market Size

7. Ophthalmic Drugs Market, by Type

8. Ophthalmic Drugs Market, by Product

9. Ophthalmic Drugs Market, by Technology

10. Ophthalmic Drugs Market, by Application

11. Ophthalmic Drugs Market, by End User

12. Ophthalmic Drugs Market, by Form

13. Ophthalmic Drugs Market, by Material Type

14. Ophthalmic Drugs Market, by Device

15. Ophthalmic Drugs Market, by Process

16. Ophthalmic Drugs Market, by Region

17. Competitive Landscape

18. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â